232 related articles for article (PubMed ID: 15183495)
1. In regard to Anagnostopoulos et al.: In vivo thermoluminescence dosimetry dose verification of transperinal (192)Ir high dose rate brachytherapy using CT-based planning for the treatment of prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:1183-1191).
Duggan L; Bucci J; Kron T
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):911; author reply 911-2. PubMed ID: 15183495
[No Abstract] [Full Text] [Related]
2. Solid state TL detectors for in vivo dosimetry in brachytherapy.
Gambarini G; Borroni M; Grisotto S; Maucione A; Cerrotta A; Fallai C; Carrara M
Appl Radiat Isot; 2012 Dec; 71 Suppl():48-51. PubMed ID: 22920417
[TBL] [Abstract][Full Text] [Related]
3. Ir-192 HDR transit dose and radial dose function determination using alanine/EPR dosimetry.
Calcina CS; de Almeida A; Rocha JR; Abrego FC; Baffa O
Phys Med Biol; 2005 Mar; 50(6):1109-17. PubMed ID: 15798311
[TBL] [Abstract][Full Text] [Related]
4. In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).
Albertini F; Lomax AJ; Hug EB
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1333-4; author reply 1334-5. PubMed ID: 17967323
[No Abstract] [Full Text] [Related]
5. Randomized trial of high- and low-source strength (125)I prostate seed implants: In regard to Narayana et al. (Int J Radiat Oncol Biol Phys 2005;61:44-51).
Moerland MA; Battermann JJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):941-2. PubMed ID: 15936582
[No Abstract] [Full Text] [Related]
6. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
[No Abstract] [Full Text] [Related]
7. Brachytherapy doses for prostate cancer customized to risk factors: is it more important "how much" or "where"? In regard to Stone et al. (Int J Radiat Oncol Biol Phys 2007;69:1472-1477).
Oton CA; Oton F
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):962; author reply 962-3. PubMed ID: 18514795
[No Abstract] [Full Text] [Related]
8. In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer.
Anagnostopoulos G; Baltas D; Geretschlaeger A; Martin T; Papagiannis P; Tselis N; Zamboglou N
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1183-91. PubMed ID: 14575851
[TBL] [Abstract][Full Text] [Related]
9. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
Yaeger TE
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
[No Abstract] [Full Text] [Related]
10. [In vivo dosimetry in interstitial "low dose rate" afterloading therapy with Ir-192 seeds exemplified with head-neck tumors].
Sadat Khonsari A; Grabenbauer G; Müller RG; Säbel M
Strahlenther Onkol; 1991 Jul; 167(7):407-11. PubMed ID: 1858017
[TBL] [Abstract][Full Text] [Related]
11. In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
Anton M; Wagner D; Selbach HJ; Hackel T; Hermann RM; Hess CF; Vorwerk H
Phys Med Biol; 2009 May; 54(9):2915-31. PubMed ID: 19384000
[TBL] [Abstract][Full Text] [Related]
12. In regard to Fiorino et al.: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:953-962).
Bauman G; Rodrigues G
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):912-4; author reply 914-5. PubMed ID: 15183497
[No Abstract] [Full Text] [Related]
13. Dosimetry of anal radiation in high-dose-rate brachytherapy for prostate cancer.
Kälkner KM; Bengtsson E; Eriksson S; Holmberg C; Nilsson S; Levitt S; Lundell M
Brachytherapy; 2007; 6(1):49-52. PubMed ID: 17284386
[TBL] [Abstract][Full Text] [Related]
14. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.).
Vordermark D; Guckenberger M; Baier K; Markert K
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):316-7. PubMed ID: 18406899
[No Abstract] [Full Text] [Related]
15. Prostate brachytherapy as monotherapy: Are there gaps, holes, and islands in the argument? In regard to Wallner et al. (Int J Radiat Oncol Biol Phys 2003;57:1297-1303).
Rubenstein J
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):305; author reply 305-6. PubMed ID: 15629630
[No Abstract] [Full Text] [Related]
16. Androgen Deprivation (AD) among low-risk and intermediate-risk prostate cancer patients: in regard to Ciezki et al. (Int J Radiat Oncol Biol Phys 2004;60:1347-1350).
Oton CA
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):291-2; author reply 292. PubMed ID: 15850937
[No Abstract] [Full Text] [Related]
17. In regards to Thames et al.: increasing external beam dose for T1-T2 prostate cancer: effect on risk groups. (Int J Radiat Oncol Biol Phys 2006;65:975-981).
Pickles T; Williams SG
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):318-9; author reply 319. PubMed ID: 17189080
[No Abstract] [Full Text] [Related]
18. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
Russi EG; Pergolizzi S; Lucio F; Ricardi U
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
[No Abstract] [Full Text] [Related]
19. Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172).
Pötter R; Dimopoulos J; Kirisits C; Lang S; Haie-Meder C; Briot E; Dumas I; Van Limbergen E; De Brabandere M; Nulens A; Erickson B; Rownd J; Petrow P
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):293-5; author reply 295-6. PubMed ID: 15850940
[No Abstract] [Full Text] [Related]
20. Comment on dose escalation and biochemical failure in prostate cancer: in regard to Kuban et al. (Int J Radiat Oncol Biol Phys 2008;70:67-74).
Schulz RJ; Kagan AR
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1288; author reply 1288-9. PubMed ID: 18572089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
